GuidesEvergreen research · not a news report
Which PDRN Is Most Effective? Injections vs Serums Ranked
The most effective PDRN is medical-grade PDRN or polynucleotides injected into the skin by a qualified practitioner, which is where nearly all the clinical evidence comes from. Clinical microneedling or laser with sterile PDRN comes next. Topical serums are the least effective, because PDRN is too large to pass easily through intact skin.
Editorial research review ·Written and reviewed by Khalid Anwar, Clinical Pharmacist, UK (GPhC 2219283)· Reviewed 11 Nov 2026· Updated 14 Oct 2026
On this page · 11 sections
Short answer: The format with the most clinical evidence is medical-grade PDRN or polynucleotides injected into the skin by a qualified practitioner, which is where nearly all the clinical evidence comes from. Clinical microneedling or laser with sterile PDRN comes next. Topical serums have the least evidence, partly because PDRN is too large to pass easily through intact skin.
Which PDRN is most effective? When people ask this, they usually mean "which will make the biggest visible difference?" The answer depends far more on how PDRN reaches your skin than on which brand you buy. This guide ranks each format by the strength of its evidence and explains what else affects results. For the different sources of PDRN, see which PDRN is best.
Key takeaways
-
Injected PDRN and polynucleotides have the most clinical evidence, though aesthetic studies are small and of low to moderate quality[3,4].
-
Delivery is the deciding factor. Molecules above about 500 daltons cross intact skin poorly, and PDRN is far larger[5,6].
-
Topical PDRN with low-molecular-weight fragments or advanced delivery may perform better than basic serums, but evidence is early[7].
-
For proven topical anti-ageing, retinoids and sunscreen remain more effective than any PDRN serum[12,13].
Why delivery decides how effective PDRN is
PDRN acts on cells in the dermis, the living layer beneath the surface where fibroblasts make collagen[1]. To work, it has to get there.
Skin is built to keep large molecules out. As a rule of thumb, molecules smaller than about 500 daltons pass through intact skin most easily[5]. Pharmaceutical PDRN has a molecular weight of 50,000 to 1,500,000 daltons, with most fragments between 80,000 and 200,000[1]. A 2025 laboratory study confirmed that native PDRN crosses a skin-like membrane slowly, which the authors attributed to its size and negative charge[6].
So the most effective PDRN is the one that bypasses the barrier, or a topical product specifically engineered to get through it.
PDRN formats, ranked by strength of evidence
This ranking reflects the amount and quality of published evidence for each format, not measured results. No study has compared injected and topical PDRN head to head, and evidence from injections or wound healing cannot be used as proof that a topical serum works.
| Rank | Format | Evidence | Best for |
|---|---|---|---|
| 1 | Injected PDRN or polynucleotides | Randomised trials and systematic reviews[2,3,4] | Skin quality, fine lines, some scars |
| 2 | Clinical microneedling or laser with sterile PDRN | Small studies and case series[8] | Texture, scars, recovery |
| 3 | Topical PDRN with advanced delivery | Early, small studies[7] | Hydration, barrier support |
| 4 | Standard serums and creams | Limited | Everyday hydration and comfort |
| 5 | Masks, toners, cleansers | Minimal for PDRN itself | Hydration boost |
1. Injected PDRN and polynucleotides
-
How: small injections into the dermis by a practitioner, usually as a course. In one acne scar study, injections were given at baseline, week 4 and week 8[9].
-
Evidence: in medicine (a wound-healing indication, not a cosmetic one), a randomised trial of 216 people with diabetic foot ulcers found complete healing in 37.3% with PDRN versus 18.9% with placebo at eight weeks[2]. In aesthetics, a systematic review of polynucleotide treatments (nine studies, 219 patients) reported improvements but rated the studies low to moderate quality[3]. A 2026 review of seven randomised trials found rejuvenation effects more modest than wound-healing effects[4].
2. Clinical microneedling or laser with sterile PDRN
-
How: tiny channels are made in the skin in a clinic, and sterile PDRN is applied straight afterwards.
-
Evidence: limited. A conference case series of three patients reported better scar improvement on PDRN-treated sides after fractional CO2 laser[8]. This is promising but far from proof.
3. Topical PDRN with advanced delivery
-
How: serums using low-molecular-weight fragments, capsules, nanoemulsions or other systems.
-
Evidence: emerging. In a 2025 study of ten people, a cream with 1% low-molecular-weight peony PDRN modestly improved under-eye elasticity after four weeks compared with a cream without it; the authors worked for the ingredient maker[7]. Clinicians are advised to judge topical PDRN on penetration data rather than marketing[10].
4. Standard topical serums and creams
-
How: everyday leave-on products listing Sodium DNA.
-
Evidence: limited. Benefits are likely to come partly or mainly from supporting ingredients such as hyaluronic acid, niacinamide and peptides.
5. Masks, toners and cleansers
-
How: occasional or rinse-off use.
-
Evidence: minimal for the PDRN itself. Masks give an immediate hydration boost; cleansers add almost nothing.
Pharmacist’s tip: If you are paying for a clinic treatment, ask the practitioner which product they use, how many sessions they recommend and what result they expect. A clear, realistic answer is a good sign.
Salmon PDRN vs plant PDRN: which is more effective?
Salmon PDRN has the research behind it, especially as an injection[1]. Plant PDRN from ginseng showed similar activity in a 2023 laboratory study[11], and some plant PDRN is produced at a lower molecular weight, which may help penetration[7]. But there are no robust head-to-head human trials. For now, salmon PDRN is the more proven choice, and plant PDRN is the credible animal-free alternative. See is PDRN vegan.
PDRN vs polynucleotides (PN)
In injectable treatments, polynucleotides are longer DNA chains than PDRN. Practitioners often choose PN for areas that benefit from more structural support, such as under the eyes, and PDRN for repair and skin quality. Neither is universally more effective, few studies compare them directly, and the right choice depends on the area and the goal[4].
What else affects how well PDRN works?
-
Your goal. PDRN is better at improving skin quality than at treating deep wrinkles, volume loss or significant sagging.
-
Consistency. Injectable courses usually involve several sessions. Topical products need six to eight weeks.
-
Sun protection. Daily sunscreen protects whatever PDRN achieves; the NHS recommends at least SPF 30 with 4-star UVA protection[13].
-
Practitioner skill. For injections, technique and product choice matter as much as the ingredient. Read are PDRN injections safe.
Questions to ask before paying for a PDRN treatment
-
Which exact product will you use, and is it PDRN or a polynucleotide (PN) product?
-
How many sessions do you recommend, how far apart, and what result is realistic for my skin?
-
What are the side effects and how long is the downtime?
-
What are your qualifications, and which professional register are you on?
-
What happens if I have a complication, and how do I contact you?
If you have a fish allergy, a bleeding disorder, an autoimmune condition or are pregnant, speak to your GP or pharmacist before booking.
Is the most effective PDRN right for you?
Not necessarily. Injections have stronger evidence but cost more, involve needles and carry injection risks. Topical products are cheap, gentle and easy. Many people combine an occasional clinic course with a daily routine of sunscreen, a retinoid if tolerated, and a PDRN serum for comfort. Our PDRN serum guide helps you choose a topical option.
The bottom line
Injected PDRN and polynucleotides have the most clinical evidence, although aesthetic studies are small. Topical PDRN is much less able to reach the deeper skin, though products with advanced delivery may do better than basic serums. Choose based on your goals, budget and comfort with needles, and treat topical products as supportive skincare rather than a substitute for treatment.
FAQs
Do PDRN serums work as well as injections?
No. Serums cannot deliver the same amount of PDRN to the dermis as injections[5,6]. They are best used for hydration and support.
How many PDRN injection sessions do I need?
Courses typically involve several sessions a few weeks apart. Your practitioner should recommend a plan based on your skin.
Does microneedling improve PDRN serum results?
Clinical microneedling with sterile PDRN can improve delivery. Do not use cosmetic serums with home microneedling devices, because they are not sterile.
Which is more effective, PDRN or retinol?
For topical anti-ageing, retinoids have far more evidence[12]. PDRN can be a gentle companion to retinol. See is PDRN retinol.
How long do PDRN injection results last?
There is little long-term data. Most studies follow people for weeks to months, so practitioners often suggest maintenance sessions[4].
Related reading
References
This article is for general information only and is not a substitute for personalised advice from a pharmacist, GP or other qualified healthcare professional. If you have a reaction or a medical concern, seek professional advice.
If you decide to try PDRN
Compare products by their ingredient lists before you buy. We have not tested them hands-on.
Get new PDRN research by email
One email a week with new guides and evidence updates. No spam; unsubscribe anytime.
Linked source records
- Mukherjee S, Date A, Patravale V, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327–348. (Tier 1, pmc.ncbi.nlm.nih.gov, retrieved 14/10/2026)
- Lee KS, Lee S, Wang H, et al. Analysis of skin regeneration and barrier-improvement efficacy of polydeoxyribonucleotide isolated from Panax ginseng adventitious root. Molecules. 2023;28(21):7240. (Tier 1, doi.org, retrieved 14/10/2026)
- Alhussain AM, et al. Polynucleotides and polydeoxyribonucleotides for skin rejuvenation, postoperative scar prevention, and wound healing: a systematic review of randomized clinical trials. Cureus. 2026;18(7). (Tier 1, doi.org, retrieved 14/10/2026)
- Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165–169. (Tier 1, pubmed.ncbi.nlm.nih.gov, retrieved 14/10/2026)
- Squadrito F, Bitto A, Irrera N, et al. Pharmacological activity and clinical use of PDRN. Frontiers in Pharmacology. 2017;8:224. (Tier 1, frontiersin.org, retrieved 14/10/2026)
- ReachMD. Polydeoxyribonucleotide in a bottle depends on formulation science. Accessed October 2026. (Tier 2, reachmd.com, retrieved 14/10/2026)
- Park M, Hwang S, Hwang JK, et al. Air-botulinum neurotoxin and polydeoxyribonucleotide injections for acne scar treatment. Aesthetic Plast Surg. 2025;49(23):6668–6674. (Tier 2, ir.ymlib.yonsei.ac.kr, retrieved 14/10/2026)
- The effectiveness of polynucleotides in esthetic medicine: a systematic review. J Cosmet Dermatol. 2025;24(2):e16721. (Tier 1, pmc.ncbi.nlm.nih.gov, retrieved 14/10/2026)
- NHS. Sunscreen and sun safety (Tier 2, NHS, retrieved 30/07/2026)
- Fernandez MD, Geraldez-Rivera A. Efficacy and safety of fractional CO2 laser with topical PDRN for acne scars in Filipino patients: a case series. IMCAS conference abstract. Accessed October 2026. (Tier 2, imcas.com, retrieved 14/10/2026)
- Park SJ, et al. Plasma-engineered PDRN: surface charge neutralization and nanosizing enhance uptake and regeneration potential. Pharmaceutics. 2025;17(9):1136. (Tier 1, doi.org, retrieved 14/10/2026)
- Bak SU, et al. Anti-aging efficacy of low-molecular-weight polydeoxyribonucleotide derived from Paeonia lactiflora. Int J Mol Sci. 2025;27(1):220. (Tier 1, pmc.ncbi.nlm.nih.gov, retrieved 14/10/2026)
- Squadrito F, Bitto A, Altavilla D, et al. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial. J Clin Endocrinol Metab. 2014;99(5):E746–E753. (Tier 1, pubmed.ncbi.nlm.nih.gov, retrieved 14/10/2026)
Something not right? Request a correction. Read our editorial policy and review methodology.